Switzerland-based drugs company Debiopharm Group has acquired a minority equity stake in local electronic marketing platform Tweasy for an undisclosed amount.
José de Bastos, chief executive of Tweasy, said: “Thanks to the Debiopharm Group, we will be able to graduate from the incubation period and accelerate our development. In practical terms, we are going to fine-tune the online platform, develop the mobile channels and begin our international expansion. Our purpose is clearly to offer the best digital toolbox on the…
